Congenital heart defects (CHDs) encompass structural abnormalities that manifest at birth, exerting an impact on both the form and function of the heart. These defects arise during fetal development when the heart is forming, and they can involve the heart valves, walls, arteries, or veins. CHDs vary widely in severity, with some causing minor issues and others posing life-threatening challenges. While the exact cause of most congenital heart defects remains unknown, certain factors such as genetic predisposition, maternal health, and environmental influences may contribute. The symptoms and consequences of CHDs can manifest at different stages of life, necessitating early detection and intervention. Advances in medical technology and surgical techniques have significantly improved the prognosis for individuals with congenital heart defects, allowing many to lead fulfilling and relatively normal lives with appropriate medical care and support. However, ongoing research and awareness efforts are crucial to further understand and address the complexities of congenital heart defects, ultimately improving outcomes and quality of life for those affected.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain